Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Touroutoglou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Thymidylate synthase inhibitorsN Touroutoglou, R Pazdur
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumorsN Touroutoglou, D Gravel, M N Raber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapyN Touroutoglou, M A Dimopoulos, A Younes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Thymidylate synthase inhibitorsN Touroutoglou, R Pazdur
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumorsN Touroutoglou, D Gravel, M N Raber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapyN Touroutoglou, M A Dimopoulos, A Younes, et al.
Pageof 1